These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34128879)

  • 1. Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer.
    Lee TH; Ryoo HG; Lee R; Paeng JC; Chung H; Kim HJ
    Medicine (Baltimore); 2021 Jun; 100(24):e26338. PubMed ID: 34128879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of standardized uptake value-based positron emission tomography and computed tomography target volumes in esophageal cancer patients undergoing radiotherapy.
    Vali FS; Nagda S; Hall W; Sinacore J; Gao M; Lee SH; Hong R; Shoup M; Emami B
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1057-63. PubMed ID: 20199850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic tumor spread beyond (echo)endoscopically determined tumor borders in esophageal cancer.
    Machiels M; van Montfoort ML; Thuijs NB; van Berge Henegouwen MI; Alderliesten T; Meijer SL; van Hooft JE; Hulshof MCCM
    Radiat Oncol; 2019 Dec; 14(1):219. PubMed ID: 31801574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful?
    Walter F; Jell C; Zollner B; Andrae C; Gerum S; Ilhan H; Belka C; Niyazi M; Roeder F
    Strahlenther Onkol; 2021 Sep; 197(9):780-790. PubMed ID: 33104815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
    Jayachandran P; Pai RK; Quon A; Graves E; Krakow TE; La T; Loo BW; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):471-7. PubMed ID: 22381904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.
    Wang YC; Hsieh TC; Yu CY; Yen KY; Chen SW; Yang SN; Chien CR; Hsu SM; Pan T; Kao CH; Liang JA
    J Radiat Res; 2012 Jul; 53(4):594-600. PubMed ID: 22843625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.
    Zhang G; Han D; Ma C; Lu J; Sun T; Liu T; Zhu J; Zhou J; Yin Y
    Radiat Oncol; 2015 Jan; 10():11. PubMed ID: 25572431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced inter-observer and intra-observer delineation variation in esophageal cancer radiotherapy by use of fiducial markers.
    Machiels M; Jin P; van Hooft JE; Gurney-Champion OJ; Jelvehgaran P; Geijsen ED; Jeene PM; Willemijn Kolff M; Oppedijk V; Rasch CRN; van Herk MB; Alderliesten T; Hulshof MCCM
    Acta Oncol; 2019 Jun; 58(6):943-950. PubMed ID: 30905243
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.
    Carvalho S; Leijenaar RT; Velazquez ER; Oberije C; Parmar C; van Elmpt W; Reymen B; Troost EG; Oellers M; Dekker A; Gillies R; Aerts HJ; Lambin P
    Acta Oncol; 2013 Oct; 52(7):1398-404. PubMed ID: 24047338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining a radiotherapy target with positron emission tomography.
    Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.
    Zhong X; Yu J; Zhang B; Mu D; Zhang W; Li D; Han A; Song P; Li H; Yang G; Kong FM; Fu Z
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):136-41. PubMed ID: 18538492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of endoscopic ultrasonography in defining longitudinal gross target volumes for esophageal squamous carcinoma.
    Qiu GQ; Du XH; Yu JP; Zheng YD; Luo HJ; Xu YP; Chen JX; Sun XJ; Ji YL; Tao YL
    Surg Laparosc Endosc Percutan Tech; 2012 Oct; 22(5):424-8. PubMed ID: 23047386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study.
    Yu J; Li X; Xing L; Mu D; Fu Z; Sun X; Sun X; Yang G; Zhang B; Sun X; Ling CC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1468-74. PubMed ID: 19464822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
    Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
    Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning for Automatic Gross Tumor Volumes Contouring in Esophageal Cancer Based on Contrast-Enhanced Computed Tomography Images: A Multi-Institutional Study.
    Zhang S; Li K; Sun Y; Wan Y; Ao Y; Zhong Y; Liang M; Wang L; Chen X; Pei X; Hu Y; Chen D; Li M; Shan H
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1590-1600. PubMed ID: 38432286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
    Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
    J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.